Phenylene-bridged
diphobane ligands with different substituents
(CF3, H, OMe, (OMe)2, tBu) have been
synthesized and applied as ligands in palladium-catalyzed carbonylation
reactions of various alkenes. The performance of these ligands in
terms of selectivity in hydroformylation versus alkoxycarbonylation
has been studied using 1-hexene, 1-octene, and methyl pentenoates
as substrates, and the results have been compared with the ethylene-bridged
diphobane ligand (BCOPE). Hydroformylation of 1-octene
in the protic solvent 2-ethyl hexanol results in a competition between
hydroformylation and alkoxycarbonylation, whereby the phenylene-bridged
ligands, in particular, the trifluoromethylphenylene-bridged diphobane L1 with an electron-withdrawing substituent, lead to ester
products via alkoxycarbonylation, whereas BCOPE gives
predominantly alcohol products (n-nonanol and isomers)
via reductive hydroformylation. The preference of BCOPE for reductive hydroformylation is also seen in the hydroformylation
of 1-hexene in diglyme as the solvent, producing heptanol as the major
product, whereas phenylene-bridged ligands show much lower activities
in this case. The phenylene-bridged ligands show excellent performance
in the methoxycarbonylation of 1-octene to methyl nonanoate, significantly
better than BCOPE, the opposite trend seen in hydroformylation
activity with these ligands. Studies on the hydroformylation of functionalized
alkenes such as 4-methyl pentenoate with phenylene-bridged ligands
versus BCOPE showed that also in this case, BCOPE directs product selectivity toward alcohols, while phenylene-bridge
diphobane L2 favors aldehyde formation. In addition to
ligand effects, product selectivities are also determined by the nature
and the amount of the acid cocatalyst used, which can affect substrate
and aldehyde hydrogenation as well as double bond isomerization.
Natural products are a rich resource of bioactive compounds for valuable applications across multiple fields such as food, agriculture, and medicine. For natural product discovery, high throughput in silico screening offers a cost-effective alternative to traditional resource-heavy assay-guided exploration of structurally novel chemical space. In this data descriptor, we report a characterized database of 67,064,204 natural product-like molecules generated using a recurrent neural network trained on known natural products, demonstrating a significant 165-fold expansion in library size over the approximately 400,000 known natural products. This study highlights the potential of using deep generative models to explore novel natural product chemical space for high throughput in silico discovery.
Natural products are a family of diverse compounds with multiple impactful applications, especially in therapeutics. Recent advances in genomics and bioinformatics have also hinted at vast untapped chemical potential within Nature. However, despite the many strategies available for activation and upregulation of natural product biosyntheses in native and heterologous microbial strains, there is yet to be a generalizable and e cient approach for interrogating diverse native strain collections. Here, we describe and demonstrate a exible and robust one-step integrase-mediated genetic-and cultivationbased approach to perturb and activate antibiotics production in a set of 54 actinobacterial strains. Our multi-pronged strategy signi cantly increases accessible metabolite space by two-fold, resulting in the discovery of the rst example of Gram-negative bioactivity in new tetramic acid analogs. We envision these results to serve as the rst step toward a more streamlined, accelerated, and scalable strategy to unlock the full potential of Nature's chemical repertoire.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.